Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 95

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan

Salk, Jesse J., Loubet-Senear, Kaitlyn, Maritschnegg, Elisabeth, Valentine, Charles C., Williams, Lindsey N., Higgins, Jacob E., Horvat, Reinhard, Vanderstichele, Adriaan, Nachmanson, Daniela, Baker, Kathryn T., Emond, Mary J., Loter, Emily, Tretiakova, Maria, Soussi, Thierry, Loeb, Lawrence A., Zeillinger, Robert, Speiser, Paul, Risques, Rosa Ana·2019·Cell Reports
DOI 10.1016/j.celrep.2019.05.109PMC PMC6639023

Published version of a preprint

Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2019.05.109

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Abyzov, 2017, One thousand somatic SNVs per skin fibroblast cell set baseline of mosaic mutational load with patterns that suggest proliferative origin, Genome Res., 27, 512, 10.1101/gr.215517.116 · DOI
  2. Ahmed, 2010, Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary, J. Pathol., 221, 49, 10.1002/path.2696 · DOI
  3. Alexandrov, 2015, Clock-like mutational processes in human somatic cells, Nat. Genet., 47, 1402, 10.1038/ng.3441 · DOI
  4. Alix-Panabières, 2016, Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy, Cancer Discov., 6, 479, 10.1158/2159-8290.CD-15-1483 · DOI · Paper page
  5. Aravanis, 2017, Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection, Cell, 168, 571, 10.1016/j.cell.2017.01.030 · DOI
  6. Bowtell, 2015, Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer, Nat. Rev. Cancer, 15, 668, 10.1038/nrc4019 · DOI
  7. Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394
  8. Chien, 2015, TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer, Nucleic Acids Res., 43, 6945, 10.1093/nar/gkv111 · DOI
  9. Diamandis, 2012, The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?, BMC Med., 10, 87, 10.1186/1741-7015-10-87 · DOI
  10. Diaz, 2014, Liquid biopsies: genotyping circulating tumor DNA, J. Clin. Oncol., 32, 579, 10.1200/JCO.2012.45.2011 · DOI · Paper page
  11. Drescher, 2018, The Yet Unrealized Promise of Ovarian Cancer Screening, JAMA Oncol., 4, 456, 10.1001/jamaoncol.2018.0028 · DOI
  12. Grossman, 2018, Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement, JAMA, 319, 588, 10.1001/jama.2017.21926 · DOI
  13. Henderson, 2018, Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force, JAMA, 319, 595, 10.1001/jama.2017.21421 · DOI · Paper page
  14. Hoang, 2016, Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing, Proc. Natl. Acad. Sci. USA, 113, 9846, 10.1073/pnas.1607794113 · DOI · Paper page
  15. Kato, 2003, Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis, Proc. Natl. Acad. Sci. USA, 100, 8424, 10.1073/pnas.1431692100 · DOI
  16. Krimmel, 2016, Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues, Proc. Natl. Acad. Sci. USA, 113, 6005, 10.1073/pnas.1601311113 · DOI
  17. Kuhn, 2012, TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions, J. Pathol., 226, 421, 10.1002/path.3023 · DOI
  18. Kurman, 2010, The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory, Am. J. Surg. Pathol., 34, 433, 10.1097/PAS.0b013e3181cf3d79 · DOI
  19. Labidi-Galy, 2017, High grade serous ovarian carcinomas originate in the fallopian tube, Nat. Commun., 8, 1093, 10.1038/s41467-017-00962-1 · DOI
  20. Lee-Six, 2018, The landscape of somatic mutation in normal colorectal epithelial cells, bioRxiv
  21. Leroy, 2014, TP53 mutations in human cancer: database reassessment and prospects for the next decade, Hum. Mutat., 35, 672, 10.1002/humu.22552 · DOI
  22. Liu, 2016, dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs, Hum. Mutat., 37, 235, 10.1002/humu.22932 · DOI
  23. Maritschnegg, 2015, Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study, J. Clin. Oncol., 33, 4293, 10.1200/JCO.2015.61.3083 · DOI
  24. Maritschnegg, 2018, Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study, Int. J. Gynecol. Cancer, 28, 1692, 10.1097/IGC.0000000000001361 · DOI
  25. Martincorena, 2018, Somatic mutant clones colonize the human esophagus with age, Science, 362, 911, 10.1126/science.aau3879 · DOI · Paper page
  26. Nair, 2016, Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study, PLoS Med., 13, e1002206, 10.1371/journal.pmed.1002206 · DOI
  27. Risques, 2018, Aging and the rise of somatic cancer-associated mutations in normal tissues, PLoS Genet., 14, e1007108, 10.1371/journal.pgen.1007108 · DOI
  28. Salk, 2018, Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations, Nat. Rev. Genet., 19, 269, 10.1038/nrg.2017.117 · DOI
  29. Schmitt, 2012, Detection of ultra-rare mutations by next-generation sequencing, Proc. Natl. Acad. Sci. USA, 109, 14508, 10.1073/pnas.1208715109 · DOI · Paper page
  30. Schmitt, 2015, Sequencing small genomic targets with high efficiency and extreme accuracy, Nat. Methods, 12, 423, 10.1038/nmeth.3351 · DOI
  31. Shain, 2015, The Genetic Evolution of Melanoma from Precursor Lesions, N. Engl. J. Med., 373, 1926, 10.1056/NEJMoa1502583 · DOI
  32. Soong, 2019, The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma, Gynecol. Oncol., 152, 426, 10.1016/j.ygyno.2018.11.033 · DOI · Paper page
  33. 2011, Integrated genomic analyses of ovarian carcinoma, Nature, 474, 609, 10.1038/nature10166 · DOI · Paper page
  34. Tikkanen, 2018, Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing, Hum. Mutat., 39, 925, 10.1002/humu.23543 · DOI
  35. Vang, 2016, Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study, Int. J. Gynecol. Pathol., 35, 48, 10.1097/PGP.0000000000000207 · DOI
  36. Wang, 2018, Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers, Sci. Transl. Med., 10, eaap8793, 10.1126/scitranslmed.aap8793 · DOI
  37. Xie, 2014, Age-related mutations associated with clonal hematopoietic expansion and malignancies, Nat. Med., 20, 1472, 10.1038/nm.3733 · DOI · Paper page
  38. Yadav, 2016, The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection, Nucleic Acids Res., 44, 2075, 10.1093/nar/gkw086 · DOI

Cited by

See all 95

Metadata

Authors
Salk, J. J., Loubet-Senear, K., Maritschnegg, E., Valentine, C. C., Williams, L. N., Higgins, J. E., Horvat, R., Vanderstichele, A., Nachmanson, D., Baker, K. T., Emond, M. J., Loter, E., Tretiakova, M., Soussi, T., Loeb, L. A., Zeillinger, R., Speiser, P., & Risques, R. A.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2019-07
Volume
28
Issue
1
Pages
132-144.e3
ISSN
2211-1247
DOI
10.1016/j.celrep.2019.05.109
PMC
PMC6639023
Cited by
95
References
12
Language
en
Licence
Funders
  • National Institutes of Health (R01CA181308)
  • Mary Kay Foundation (045-15, 174261, 567612, CA077852, CA193649, R44CA221426, T32CA009515)
  • Small Business Innovation Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review